Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 455,763 |
|
|||||
| News | - | ||||||
| Day High | 18.12 | Low High |
|||||
| Day Low | 17.38 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.14 | 0.80% | 17.68 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 17.57 | 17.38 | 18.12 | 17.68 | 17.54 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,980 | 455,763 | $ 17.70 | $ 8,066,308 | - | 8.20 - 18.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:51:20 | average | 60,533 | $ 17.68 | USD |
iTeos Therapeutics (ITOS) Options Flow Summary
iTeos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 633.35M | 35.84M | - | 12.6M | -112.64M | -3.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
iTeos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.91 | 18.70 | 17.38 | 17.92 | 387,580 | -0.23 | -1.28% |
| 1 Month | 10.59 | 18.75 | 10.55 | 16.40 | 648,994 | 7.09 | 66.95% |
| 3 Months | 10.78 | 18.75 | 10.01 | 14.30 | 404,840 | 6.90 | 64.01% |
| 6 Months | 9.67 | 18.75 | 8.95 | 12.55 | 354,282 | 8.01 | 82.83% |
| 1 Year | 15.41 | 18.75 | 8.20 | 12.27 | 395,508 | 2.27 | 14.73% |
| 3 Years | 22.32 | 52.43 | 8.20 | 21.23 | 375,680 | -4.64 | -20.79% |
| 5 Years | 19.70 | 52.43 | 8.20 | 22.39 | 339,115 | -2.02 | -10.25% |
iTeos Therapeutics Description
| ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |
